Intellipharmaceutics International Inc. (NASDAQ: IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that its United States subsidiary,Intellipharmaceutics Ltd., has appointed Ira Baeringer as its Vice President, Business Development, effective February 1, 2012.
Mr. ...
Continue Reading →
30
JAN
JAN
0
Share
